Supplemental material
Open access
1,014
Views
0
CrossRef citations to date
0
Altmetric
Research Article
Comparison between super-responders and non-super-responders in psoriasis under adalimumab treatment: a real-life cohort study on the effectiveness and drug survival over one-year
Yizhang Liua Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China;b National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Changsha, China;c Furong Laboratory, Changsha, China;d National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Changsha, China;e Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Changsha, China;f Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, Changsha, China;g Xiangya Clinical Research Center for Cancer Immunotherapy, Central South University, Changsha, Chinahttps://orcid.org/0009-0001-0465-2829View further author information
, Kun Hua Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China;b National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Changsha, China;c Furong Laboratory, Changsha, China;d National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Changsha, China;e Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Changsha, China;f Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, Changsha, China;g Xiangya Clinical Research Center for Cancer Immunotherapy, Central South University, Changsha, Chinahttps://orcid.org/0000-0001-9717-4012View further author information
, Lu Jiana Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China;b National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Changsha, China;c Furong Laboratory, Changsha, China;d National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Changsha, China;e Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Changsha, China;f Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, Changsha, China;g Xiangya Clinical Research Center for Cancer Immunotherapy, Central South University, Changsha, Chinahttps://orcid.org/0000-0002-7701-3649View further author information
, Yongfang Duana Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China;b National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Changsha, China;c Furong Laboratory, Changsha, China;d National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Changsha, China;e Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Changsha, China;f Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, Changsha, China;g Xiangya Clinical Research Center for Cancer Immunotherapy, Central South University, Changsha, Chinahttps://orcid.org/0009-0001-7502-2066View further author information
, Mi Zhanga Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China;b National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Changsha, China;c Furong Laboratory, Changsha, China;d National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Changsha, China;e Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Changsha, China;f Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, Changsha, China;g Xiangya Clinical Research Center for Cancer Immunotherapy, Central South University, Changsha, ChinaCorrespondence[email protected]
https://orcid.org/0000-0001-6795-0076View further author information
& https://orcid.org/0000-0001-6795-0076View further author information
Yehong Kuanga Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China;b National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Changsha, China;c Furong Laboratory, Changsha, China;d National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Changsha, China;e Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Changsha, China;f Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, Changsha, China;g Xiangya Clinical Research Center for Cancer Immunotherapy, Central South University, Changsha, ChinaCorrespondence[email protected]
https://orcid.org/0000-0002-1133-1791View further author information
https://orcid.org/0000-0002-1133-1791View further author information
Article: 2331782
|
Received 14 Nov 2023, Accepted 25 Dec 2023, Published online: 21 Mar 2024
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.